Andrew Armstrong, MD, has received a Department of Defense Prostate Cancer Research Program Physician Research Training Award for $685,172 from July 1, 2010 to June 30 2015. The funds will be used to study circulating tumor cell biology in men with advanced prostate cancer and is in collaboration with Dan George, MD, Phillip Febbo, MD, Simon Gregory, PhD, and Mariano Garcia-Blanco, MD, PhD.

The National Brain Tumor Society presented its first "Founders Award for Research Excellence" jointly to The Cancer Genome Atlas Research Group, and The Johns Hopkins Kimmel Cancer Center and Duke University Medical Center Group, respectively. The award recognized their ground-breaking work in the major collective advancement in the genomic analysis of gliomas. The Duke group includes Darell Bigner, MD, PhD; Hai Yan, MD, PhD; Roger McLendon, MD; B. Ahmed Rasheed, PhD; and Stephen Keir, DrPH, MPH.

October 21, 2009--Cancer Center member Huntington Willard, PhD, will receive 2009 William Allan Award from the American Society of Human Genetics. The society is the primary professional membership organization for human genetics specialists worldwide, representing nearly 8,000 researchers, academicians, clinicians, genetic counselors, nurses and others with a special interest in this area. The Allan Award recognizes substantial and far-reaching scientific contributions to human genetics, carried out over a lifetime of scientific inquiry and productivity.

Judd Moul, MD, was recently appointed to the American Joint Committee on Cancer (AJCC) representing the American Urological Association. The AJCC was established in 1959 to formulate and publish systems of classification of cancer, including staging and end results reporting, which will be acceptable to and used by the medical profession for selecting the most effective treatment, determining prognosis, and continuing evaluation of cancer control measures. The AJCC is comprised of six founding organizations, four sponsoring organizations, and eleven liaison organizations.

September 2, 2009--S. David Hsu, MD, PhD, and Anil Potti, MD, have received a translational grant from The V Foundation for their research on "Development of a paraffin-based assay to predict patients with early stage colorectal cancer at high risk for recurrence." The award is for $600,000 over three years.